MXPA04000065A - Derivados de aril(o ehteroaril)azolilcarbinoles para el tratamiento de la incontinencia urinaria. - Google Patents

Derivados de aril(o ehteroaril)azolilcarbinoles para el tratamiento de la incontinencia urinaria.

Info

Publication number
MXPA04000065A
MXPA04000065A MXPA04000065A MXPA04000065A MXPA04000065A MX PA04000065 A MXPA04000065 A MX PA04000065A MX PA04000065 A MXPA04000065 A MX PA04000065A MX PA04000065 A MXPA04000065 A MX PA04000065A MX PA04000065 A MXPA04000065 A MX PA04000065A
Authority
MX
Mexico
Prior art keywords
derivatives
azolylcarbynol
heteroaryl
aryl
treatment
Prior art date
Application number
MXPA04000065A
Other languages
English (en)
Spanish (es)
Inventor
Merce-Vidal Ramon
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of MXPA04000065A publication Critical patent/MXPA04000065A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA04000065A 2001-07-06 2002-07-01 Derivados de aril(o ehteroaril)azolilcarbinoles para el tratamiento de la incontinencia urinaria. MXPA04000065A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200101587A ES2180449B1 (es) 2001-07-06 2001-07-06 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
PCT/ES2002/000326 WO2003004022A1 (es) 2001-07-06 2002-07-01 Derivados de aril(o heteroaril)azolilcarbinoles para el tratamiento de la incontinencia urinaria

Publications (1)

Publication Number Publication Date
MXPA04000065A true MXPA04000065A (es) 2004-05-21

Family

ID=8498326

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04000065A MXPA04000065A (es) 2001-07-06 2002-07-01 Derivados de aril(o ehteroaril)azolilcarbinoles para el tratamiento de la incontinencia urinaria.

Country Status (23)

Country Link
US (2) US20030022925A1 (enExample)
EP (1) EP1413305B1 (enExample)
JP (1) JP2004521150A (enExample)
KR (1) KR20040030788A (enExample)
CN (1) CN1543344A (enExample)
AR (1) AR034679A1 (enExample)
AT (1) ATE327752T1 (enExample)
BR (1) BR0211237A (enExample)
CA (1) CA2452646A1 (enExample)
CY (1) CY1105113T1 (enExample)
DE (1) DE60211913T2 (enExample)
DK (1) DK1413305T3 (enExample)
ES (2) ES2180449B1 (enExample)
MA (1) MA27056A1 (enExample)
MX (1) MXPA04000065A (enExample)
NO (1) NO20040031L (enExample)
NZ (1) NZ530817A (enExample)
PL (1) PL369062A1 (enExample)
PT (1) PT1413305E (enExample)
RU (1) RU2308268C2 (enExample)
UA (1) UA79238C2 (enExample)
WO (1) WO2003004022A1 (enExample)
ZA (1) ZA200400780B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
DE10335566A1 (de) * 2003-07-31 2005-02-24 Grünenthal GmbH Arzneimittel enthaltend Derivate von Aryl( oder Heteroaryl)azolylcarbinolen
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
ES2244326B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
EP1784178A1 (en) * 2004-07-30 2007-05-16 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
EP1757587A1 (en) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743890A1 (en) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
US20070021485A1 (en) * 2005-07-22 2007-01-25 Gomis Antonio F Aryl (or heteroaryl) azolylcarbinols
WO2007017127A2 (en) * 2005-07-29 2007-02-15 Laboratorios Del Dr. Esteve, S.A Controlled realease dosage form of pirazole compounds to treat urinary incontinence
US8722079B2 (en) 2008-04-18 2014-05-13 Warsaw Orthopedic, Inc. Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
EP2151234A1 (en) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
US20100291151A1 (en) * 2009-04-21 2010-11-18 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE891865A (fr) * 1981-01-30 1982-07-22 Sandoz Sa Nouveaux medicaments a base de derives condenses de l'imidazole pour le traitement des troubles urinaires
FR2613720B1 (fr) * 1987-04-10 1990-01-19 Esteve Labor Dr Derives d'aryl-heteroaryl carbinols avec activite analgesique
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378B1 (es) * 1998-08-07 2001-07-01 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.

Also Published As

Publication number Publication date
ES2263792T3 (es) 2006-12-16
DE60211913T2 (de) 2007-05-24
BR0211237A (pt) 2004-08-10
EP1413305B1 (en) 2006-05-31
CN1543344A (zh) 2004-11-03
DK1413305T3 (da) 2006-09-18
ES2180449B1 (es) 2004-01-16
RU2308268C2 (ru) 2007-10-20
US20030022925A1 (en) 2003-01-30
ZA200400780B (en) 2005-01-31
AR034679A1 (es) 2004-03-03
NZ530817A (en) 2005-07-29
EP1413305A1 (en) 2004-04-28
ATE327752T1 (de) 2006-06-15
NO20040031L (no) 2004-03-02
MA27056A1 (fr) 2004-12-20
JP2004521150A (ja) 2004-07-15
US20050131049A1 (en) 2005-06-16
PT1413305E (pt) 2006-09-29
UA79238C2 (en) 2007-06-11
KR20040030788A (ko) 2004-04-09
PL369062A1 (en) 2005-04-18
ES2180449A1 (es) 2003-02-01
CA2452646A1 (en) 2003-01-16
DE60211913D1 (de) 2006-07-06
RU2004103475A (ru) 2005-06-10
CY1105113T1 (el) 2010-03-03
WO2003004022A1 (es) 2003-01-16

Similar Documents

Publication Publication Date Title
MXPA04000065A (es) Derivados de aril(o ehteroaril)azolilcarbinoles para el tratamiento de la incontinencia urinaria.
IL164511A0 (en) Heterocyclic compounds
MY137039A (en) Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
JO2282B1 (en) Oxazole derivatives
MXPA05012415A (es) Inhibidores de glutamina fructosa-3-fosfato amidotransferasa (gfat).
ATE537830T1 (de) Nicotinamid derivate und ihre verwendung als therapeutika
IL164613A0 (en) Thienyl compounds
SE0401971D0 (sv) Piperidne derivatives
ATE349432T1 (de) 2-anilino-pyrimidin-derivate als cyclin-abhängige kinase hemmer
GEP20135983B (en) 1-benzyl-3-hydroxymethylindazole derivatives and usage therein treatment of diseases based on mcp-1, cx3cr1 and p40 expression
TNSN06377A1 (en) Combinations of glycopyrrolate and beta2 adrenoceptor agonists
NZ513096A (en) Compositions for treating inflammatory response
GB0314967D0 (en) Piperazine derivatives
MY140630A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
BG108498A (en) New derivatives of oxazolidinones as antibacterial agents
DK1483251T3 (da) C3-cyano-epothilon-derivater
TW200504029A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MY139676A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
NO20063619L (no) Diarylmetylpiperazinderivater, fremstilling og anvendelse derav
NZ599554A (en) ((phenyl)imidazolyl)methylheteroaryl compounds
IL158268A0 (en) Azolylcarbinol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
BR0108002A (pt) Derivados de amidas heterocìclicas
TW200510312A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
EP2266566A3 (en) Nicotinamide derivatives and their use as therapeutic agents